Dose: Protocols often use a higher total amount, typically between 2mg and 5mg per week
This hypothesis was supported in a recent study with a 20-year follow-up, which found chronic low dose exposure to POPs predicted excess adiposity, dyslipidemia, and insulin resistance among participants without diabetes, in a U-shaped fashion (characteristic of endocrine disruption)
Similarly, introducing a medication like semaglutide at its highest effective dose from the outset can overwhelm your system, leading to uncomfortable and potentially disruptive side effects, particularly gastrointestinal issues such as nausea, vomiting, or diarrhea
Glossary GLP-1 (Glucagon-Like Peptide-1) An incretin hormone produced in the gut that suppresses appetite, slows gastric emptying, and promotes insulin secretion